Every material Form 8-K MetLife filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
MetLife reported its third-quarter 2026 financial results, highlighted by net income of $2.4 billion, or $3.67 per share, driven by net derivative gains and higher adjusted earnings. Adjusted earnings increased 12% to $1.8 billion, supported by higher variable investment income, broad-based volume growth, and favorable underwriting. The company returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter.
Net income increased 187% to $2.4 billion, or $3.67 per share, for the third quarter of 2026.
Adjusted earnings rose 12% to $1.8 billion, or $2.78 per share.
Premiums, fees and other revenues increased 12% to $14.1 billion.
Total assets under management for MetLife Investment Management reached $723.4 billion.
MetLife reported results for the quarter ended June 30, 2026, with adjusted earnings up 15% to $1.6 billion and adjusted earnings per share up 20% to $2.43. Net income rose 1% to $705 million, or $1.09 per share, and premiums, fees and other revenues grew 7% to $13.7 billion. The board also approved a new $3.0 billion authorization to repurchase common stock.
Adjusted earnings rose 15% to $1.6 billion ($1,573 million); adjusted earnings per share rose 20% to $2.43.
Net income rose 1% to $705 million, or $1.09 per share, up 6% on a per-share basis.
Premiums, fees and other revenues rose 7% to $13.7 billion; net investment income rose 18% to $6.7 billion.
On August 5, 2026, the board approved a new $3.0 billion common stock repurchase authorization.
MetLife reported first-quarter 2026 results that improved on the prior-year quarter, with net income up 30% to $1.1 billion and adjusted earnings up 18% to $1.6 billion. Adjusted premiums, fees and other revenues excluding pension risk transfers rose 10% to $13.3 billion, and the company returned over $1.1 billion to shareholders through buybacks and dividends.
Net income was $1.1 billion, or $1.74 per share, up 30% (36% per share); adjusted earnings per share rose 23% to $2.42.
Premiums, fees and other revenues rose 5% to $14.3 billion; excluding pension risk transfers, they rose 10% to $13.3 billion.
Variable investment income rose 58% to $518 million, driven by higher private equity returns.
Holding company cash and liquid assets totaled $3.9 billion at March 31, 2026, at the top of the target range.
MetLife's Board increased its size from eleven to thirteen directors and elected Daniel S. Glaser and Michelle R. Seitz, both determined to be independent. The new directors receive the standard non-management director pay, which is a $355,000 annual retainer split between shares and cash.
Board expanded from eleven to thirteen directors on February 24, 2026, effective immediately
Glaser joins the Audit, Compensation, and Finance and Risk committees; Seitz joins the Compensation, Governance and Corporate Responsibility, and Investment committees
Standard non-management retainer is $355,000 per year: $205,000 in company stock and $150,000 in cash, with partial-year service pro-rated
MetLife reported fourth-quarter 2025 net income of $778 million, or $1.17 per share, down 37% from a year earlier, mainly due to net derivative and investment losses. Adjusted earnings per share excluding total notable items rose 24% to $2.58, and the company maintained its near-term 2026 targets for adjusted return on equity and double-digit adjusted EPS growth. The mixed picture matters to shareholders because reported profit fell sharply while the company's adjusted measures and revenue grew.
Q4 net income was $778 million ($1.17 per share), versus $1,239 million ($1.78 per share) a year earlier; net derivative losses were $646 million.
Q4 adjusted EPS excluding total notable items rose 24% to $2.58; full-year figure was $8.89, up 10%.
Q4 premiums, fees and other revenues rose 29% to $18.7 billion; adjusted PFOs excluding pension risk transfers rose 8% to $12.8 billion.
2026 outlook maintains adjusted ROE target of 15%-17% and expects the direct expense ratio to be 12.1% for 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every MetLife filing is on SEC EDGAR ↗. 8-K briefs of other companies →